Drug Type Small molecule drug |
Synonyms EMD 52692, EMD-52692, SR-44866 |
Target |
Action activators |
Mechanism KATP channels activators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC17H14N2O2 |
InChIKeyJTVSKASWNROQQF-UHFFFAOYSA-N |
CAS Registry117545-11-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Bimakalim | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Angina Pectoris | Phase 2 | United States | - | - |
Angina Pectoris | Phase 2 | Germany | - | |
Angina Pectoris | Phase 2 | Italy | - | - |
Angina Pectoris | Phase 2 | - | - | |
Asthma | Phase 2 | United States | - | - |
Asthma | Phase 2 | Germany | - | |
Asthma | Phase 2 | Italy | - | - |
Asthma | Phase 2 | - | - | |
Heart Failure | Phase 2 | Germany | - | |
Heart Failure | Phase 2 | Italy | - | - |